DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)
- 0.0085
- -0.0084-49.70%
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) News
8-K: Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
8-K: Current report
8-K: Current report
8-K: Current report
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | DEFA14A: Others
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | DEF 14A: Definitive information statements
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Current report
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | PRE 14A: Preliminary proxy statements relating to merger or acquisition
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Current report
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | DEF 14A: Definitive information statements
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | S-3: Registration statement for specified transactions by certain issuers
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | PRE 14A: Preliminary proxy statements relating to merger or acquisition
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Current report
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Current report
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | 8-K: Current report
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | DEFA14A: Others
DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) | S-1: General form for registration of securities under the Securities Act of 1933
Analysis
Price Target
No Data
